Journal of NeuroInterventional Surgery-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：磁共振;介入;斑块 经验分享：技术问题当天回复一个月内给修改意见返修以后一周内给结果 proof后4天就在线发表了不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚见刊，今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快，格式上问题转天就通知修改。杂志偏向介入外科、技术方向，跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回（专硕临床忙没时间修改到最后截止时间） 5.31 Accept 4个审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗？HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。HawkingS 2016-12-14 16:34:00 发表: 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天，接收后约15天onlineHawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834958, encodeId=f59f83495872, content=期刊范围包括神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。 收稿率：48% 投稿至初步决定：平均22天 接收至发表：平均15天（线上发表）平均9个月（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9d5414052, createdName=ms7780612574685936, createdTime=Wed Dec 14 16:31:02 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2024-02-03 ms8000001452311796 来自广东省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：磁共振;介入;斑块
经验分享：技术问题当天回复一个月内给修改意见返修以后一周内给结果 proof后4天就在线发表了不用版面费

17 0

[GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：磁共振;介入;斑块 经验分享：技术问题当天回复一个月内给修改意见返修以后一周内给结果 proof后4天就在线发表了不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚见刊，今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快，格式上问题转天就通知修改。杂志偏向介入外科、技术方向，跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回（专硕临床忙没时间修改到最后截止时间） 5.31 Accept 4个审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗？HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。HawkingS 2016-12-14 16:34:00 发表: 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天，接收后约15天onlineHawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834958, encodeId=f59f83495872, content=期刊范围包括神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。 收稿率：48% 投稿至初步决定：平均22天 接收至发表：平均15天（线上发表）平均9个月（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9d5414052, createdName=ms7780612574685936, createdTime=Wed Dec 14 16:31:02 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2023-06-28 ms5000000862989212

审稿速度:1.0 | 投稿命中率:50.0
经验分享：刚见刊，今年if跌得也太狠了吧……

21 0

[GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：磁共振;介入;斑块 经验分享：技术问题当天回复一个月内给修改意见返修以后一周内给结果 proof后4天就在线发表了不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚见刊，今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快，格式上问题转天就通知修改。杂志偏向介入外科、技术方向，跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回（专硕临床忙没时间修改到最后截止时间） 5.31 Accept 4个审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗？HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。HawkingS 2016-12-14 16:34:00 发表: 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天，接收后约15天onlineHawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834958, encodeId=f59f83495872, content=期刊范围包括神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。 收稿率：48% 投稿至初步决定：平均22天 接收至发表：平均15天（线上发表）平均9个月（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9d5414052, createdName=ms7780612574685936, createdTime=Wed Dec 14 16:31:02 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2022-01-21 N.Yan

流程很快，格式上问题转天就通知修改。杂志偏向介入外科、技术方向，跟介入治疗、技术不相关的基本一周内就拒了

58 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：磁共振;介入;斑块 经验分享：技术问题当天回复一个月内给修改意见返修以后一周内给结果 proof后4天就在线发表了不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚见刊，今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快，格式上问题转天就通知修改。杂志偏向介入外科、技术方向，跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回（专硕临床忙没时间修改到最后截止时间） 5.31 Accept 4个审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗？HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。HawkingS 2016-12-14 16:34:00 发表: 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天，接收后约15天onlineHawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834958, encodeId=f59f83495872, content=期刊范围包括神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。 收稿率：48% 投稿至初步决定：平均22天 接收至发表：平均15天（线上发表）平均9个月（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9d5414052, createdName=ms7780612574685936, createdTime=Wed Dec 14 16:31:02 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2021-06-01 183431125am

审稿速度:1.0 | 投稿命中率:50.0
经验分享：杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回（专硕临床忙没时间修改到最后截止时间） 5.31 Accept 4个审稿专家意见都很中肯

115 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：磁共振;介入;斑块 经验分享：技术问题当天回复一个月内给修改意见返修以后一周内给结果 proof后4天就在线发表了不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚见刊，今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快，格式上问题转天就通知修改。杂志偏向介入外科、技术方向，跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回（专硕临床忙没时间修改到最后截止时间） 5.31 Accept 4个审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗？HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。HawkingS 2016-12-14 16:34:00 发表: 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天，接收后约15天onlineHawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834958, encodeId=f59f83495872, content=期刊范围包括神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。 收稿率：48% 投稿至初步决定：平均22天 接收至发表：平均15天（线上发表）平均9个月（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9d5414052, createdName=ms7780612574685936, createdTime=Wed Dec 14 16:31:02 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2021-12-28 msSSSSSD

qPCR的结果如何处理？

51 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：磁共振;介入;斑块 经验分享：技术问题当天回复一个月内给修改意见返修以后一周内给结果 proof后4天就在线发表了不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚见刊，今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快，格式上问题转天就通知修改。杂志偏向介入外科、技术方向，跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回（专硕临床忙没时间修改到最后截止时间） 5.31 Accept 4个审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗？HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。HawkingS 2016-12-14 16:34:00 发表: 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天，接收后约15天onlineHawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834958, encodeId=f59f83495872, content=期刊范围包括神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。 收稿率：48% 投稿至初步决定：平均22天 接收至发表：平均15天（线上发表）平均9个月（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9d5414052, createdName=ms7780612574685936, createdTime=Wed Dec 14 16:31:02 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2021-12-27 衣谷

我的结果中有视频结果可以么？

44 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：磁共振;介入;斑块 经验分享：技术问题当天回复一个月内给修改意见返修以后一周内给结果 proof后4天就在线发表了不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚见刊，今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快，格式上问题转天就通知修改。杂志偏向介入外科、技术方向，跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回（专硕临床忙没时间修改到最后截止时间） 5.31 Accept 4个审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗？HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。HawkingS 2016-12-14 16:34:00 发表: 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天，接收后约15天onlineHawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834958, encodeId=f59f83495872, content=期刊范围包括神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。 收稿率：48% 投稿至初步决定：平均22天 接收至发表：平均15天（线上发表）平均9个月（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9d5414052, createdName=ms7780612574685936, createdTime=Wed Dec 14 16:31:02 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2019-09-03 zmc217

请问下收版面费吗？HawkingS 2016-12-14 发表::
研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。HawkingS 2016-12-14 16:34:00 发表:
2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。

HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。

161 0

[GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：磁共振;介入;斑块 经验分享：技术问题当天回复一个月内给修改意见返修以后一周内给结果 proof后4天就在线发表了不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚见刊，今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快，格式上问题转天就通知修改。杂志偏向介入外科、技术方向，跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回（专硕临床忙没时间修改到最后截止时间） 5.31 Accept 4个审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗？HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。HawkingS 2016-12-14 16:34:00 发表: 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天，接收后约15天onlineHawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834958, encodeId=f59f83495872, content=期刊范围包括神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。 收稿率：48% 投稿至初步决定：平均22天 接收至发表：平均15天（线上发表）平均9个月（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9d5414052, createdName=ms7780612574685936, createdTime=Wed Dec 14 16:31:02 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2016-12-14 HawkingS2832

审稿速度:1.0 | 投稿命中率:50.0
经验分享：2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。

336 0

[GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：磁共振;介入;斑块 经验分享：技术问题当天回复一个月内给修改意见返修以后一周内给结果 proof后4天就在线发表了不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚见刊，今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快，格式上问题转天就通知修改。杂志偏向介入外科、技术方向，跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回（专硕临床忙没时间修改到最后截止时间） 5.31 Accept 4个审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗？HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。HawkingS 2016-12-14 16:34:00 发表: 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天，接收后约15天onlineHawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834958, encodeId=f59f83495872, content=期刊范围包括神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。 收稿率：48% 投稿至初步决定：平均22天 接收至发表：平均15天（线上发表）平均9个月（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9d5414052, createdName=ms7780612574685936, createdTime=Wed Dec 14 16:31:02 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2016-12-14 HawkingS2832

一审平均22天，接收后约15天onlineHawkingS 2016-12-14 发表::
接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。

HawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。

375 0

[GetPortalCommentsPageByObjectIdResponse(id=2185607, encodeId=dc00218560e12, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：磁共振;介入;斑块 经验分享：技术问题当天回复一个月内给修改意见返修以后一周内给结果 proof后4天就在线发表了不用版面费, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=17, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7f0c8287526, createdName=ms8000001452311796, createdTime=Sat Feb 03 09:22:05 CST 2024, time=2024-02-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2145230, encodeId=cad72145230c5, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：刚见刊，今年if跌得也太狠了吧……, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=92de5423989, createdName=ms5000000862989212, createdTime=Wed Jun 28 16:27:28 CST 2023, time=2023-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1187002, encodeId=468b118e002ef, content=流程很快，格式上问题转天就通知修改。杂志偏向介入外科、技术方向，跟介入治疗、技术不相关的基本一周内就拒了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211222/a321bf2a72ea4a0b918a3b3c7a55fe16/421d74e0c15d425e818725fe36a0068b.jpg, createdBy=a3fe5456523, createdName=N.Yan, createdTime=Fri Jan 21 22:13:16 CST 2022, time=2022-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=969986, encodeId=ac60969986a9, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：杂志审稿速度飞快 3.15 Submission 3.25 Major revision 5.26修回（专硕临床忙没时间修改到最后截止时间） 5.31 Accept 4个审稿专家意见都很中肯, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=115, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=71b74765680, createdName=183431125am, createdTime=Tue Jun 01 01:59:53 CST 2021, time=2021-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103923, encodeId=e10f1103923dc, content=qPCR的结果如何处理？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:52 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1103924, encodeId=3b18110392426, content=我的结果中有视频结果可以么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=44, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:52 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575787, encodeId=a3635e578766, content=请问下收版面费吗？HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。HawkingS 2016-12-14 16:34:00 发表: 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 研究方向：外科; 接收率：约50% 审稿时间：约1个月 SCI(2015)：2.959 SCI(2014)：2.774 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=161, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20150803/IMG55BEBEED705DA2486.jpg, createdBy=673582621, createdName=zmc217, createdTime=Tue Sep 03 00:00:00 CST 2019, time=2019-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530592, encodeId=0bda53059218, content=审稿速度:1.0 | 投稿命中率:50.0 经验分享：2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=336, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=530594, encodeId=f20c53059493, content=一审平均22天，接收后约15天onlineHawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, beContent=HawkingS 2016-12-14 发表:: 接收率：约50% 审稿时间：约1个月 2009年创刊后，迅速成长为神经介入领域的首选期刊之一。期刊关注用神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=375, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20151122/IMG5651CF662329D6462.jpg, createdBy=add21665252, createdName=HawkingS2832, createdTime=Wed Dec 14 16:34:00 CST 2016, time=2016-12-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834958, encodeId=f59f83495872, content=期刊范围包括神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。 收稿率：48% 投稿至初步决定：平均22天 接收至发表：平均15天（线上发表）平均9个月（纸刊发表） , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff9d5414052, createdName=ms7780612574685936, createdTime=Wed Dec 14 16:31:02 CST 2016, time=2016-12-14, status=1, ipAttribution=)]

2016-12-14 ms7780612574685936

期刊范围包括神经介入技术治疗神经病及神经血管疾病，包括中风、动脉瘤、血管畸形、脑肿瘤、头颈部疾病和脊椎病等。
收稿率：48%
投稿至初步决定：平均22天
接收至发表：平均15天（线上发表）平均9个月（纸刊发表）

104 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务